Impact of immunotherapy on intracranial progression-free survival in patients with advanced lung cancer and melanoma with brain metastasis: A single-center retrospective study and comparison of the pre- and post-immunotherapy era.

被引:0
|
作者
Kim, Do Young
Mohammadi, Oranus
Omenuko, Nnamdi J.
Sant, Ashley
Lewis, Nicole
Jaishankar, Devapiran
Chakraborty, Kanishka
机构
[1] East Tennessee State Univ, Quillen Coll Med, Div Med Oncol, Johnson City, TN USA
[2] East Tennessee State Univ, Coll Publ Hlth, Dept Epidemiol, Johnson City, TN USA
[3] Ballad Hlth Canc Care, Johnson City, TN USA
[4] East Tennessee State Univ, Quillen Coll Med, Dept Med Educ, Johnson City, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14005
引用
收藏
页数:1
相关论文
共 42 条
  • [1] Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis
    Grambozov, Brane
    Wass, Romana
    Stana, Markus
    Gerum, Sabine
    Karner, Josef
    Fastner, Gerd
    Studnicka, Michael
    Sedlmayer, Felix
    Zehentmayr, Franz
    THORACIC CANCER, 2021, 12 (08) : 1162 - 1170
  • [2] Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study
    Vakkalagadda, C.
    Bucheit, L.
    Sun, Z.
    Kocherginsky, M.
    Chae, Y. K.
    Boumber, Y.
    Mohindra, N. A.
    Patel, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S410 - S410
  • [3] The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Santomaggio, Carmine
    Carini, Marco
    Mazzanti, Roberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : 704 - 710
  • [4] The Impact of Kinlessness on Survival in Patients With Advanced Non-small Cell Lung Cancer: A Single-Center Retrospective Study
    Omura, Akiisa
    Nojiri, Takashi
    Higashiyama, Masahiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [5] Real-world survival outcomes of immunotherapy for advanced non-small cell lung cancer: A single-center retrospective review
    Punchhi, Gopika
    Hussein, Abdulkadir
    Kulkarni, Swati
    THORACIC CANCER, 2024, 15 (05) : 394 - 401
  • [6] Overall and progression-free survival in endometrial carcinoma: a single-center retrospective study of patients treated between 2000-2018
    Anfinan, Nisreen
    Sait, Khalid Hussain
    Sait, Hesham Khalid
    Alshamrani, Hanan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A154 - A155
  • [7] Overall and progression-free survival in endometrial carcinoma: A single-center retrospective study of patients treated between 2000-2018
    Sait, Khalid H.
    Anfinan, Nisreen
    Sait, Hesham
    Shamrani, Hanan
    Sait, Maram
    ANNALS OF SAUDI MEDICINE, 2023, 43 (05) : 315 - 328
  • [8] Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
    Xie, Dong
    Xu, Fangyi
    Zhu, Wenchao
    Pu, Cailing
    Huang, Shaoyu
    Lou, Kaihua
    Wu, Yan
    Huang, Dingpin
    He, Cong
    Hu, Hongjie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
    Dimitrakopoulos, Foteinos-Ioannis
    Nikolakopoulos, Achilleas
    Kottorou, Anastasia
    Kalofonou, Fotini
    Liolis, Elias
    Frantzi, Theodora
    Pyrousis, Ioannis
    Koutras, Angelos
    Makatsoris, Thomas
    Kalofonos, Haralabos
    CANCERS, 2020, 12 (05)
  • [10] Upfront brain radiotherapy improves intracranial progression-free survival but not overall survival in lung adenocarcinoma patients with brain metastases: a retrospective, single-institutional analysis from China
    Jiang, Aijun
    Ni, Meng
    Li, Li
    Zhao, Fen
    Yao, Yuanhu
    Ding, Xin
    Yu, Qingxi
    Zhang, Longzhen
    Yuan, Shuanghu
    JOURNAL OF CANCER, 2022, 13 (02): : 602 - 609